A study published August 15, 2026 in the European Journal of Medical Research adds a specific piece to the fatty-liver-and-heart story: diastolic function. The cross-sectional study of 3,240 hospitalized adults found that MASLD was independently associated with early left-ventricular diastolic dysfunction - the heart’s trouble relaxing and filling between beats - even after accounting for the usual confounders. The question the authors set out to settle was whether MASLD links to this early heart change on its own, rather than only through shared risk factors like obesity and diabetes.
The population matters because it is large and Asian, which closes a gap the authors name explicitly: most prior evidence on the MASLD-heart link came from smaller or Western cohorts. Diastolic dysfunction is the earliest detectable cardiac change in many people, long before symptoms or ejection-fraction problems, so catching a signal here means the liver-heart conversation starts earlier than most patients expect.
What diastolic dysfunction actually is
Diastolic dysfunction is a stiffness problem, not a pumping problem. Between heartbeats the left ventricle must relax and fill with blood; when the muscle is stiffer than it should be, it fills less easily, and pressure backs up. It is the precursor to heart failure with preserved ejection fraction (HFpEF) - the form of heart failure that is rising fastest and that has few proven treatments. The liver connection matters because MASLD and diastolic dysfunction share a metabolic root: insulin resistance, visceral fat, and low-grade inflammation all stiffen both organs at once.
The study also folded in liver fibrosis risk, because the researchers wanted to know whether the stage of liver disease - not just the presence of fat - sharpens the heart signal. The framing is the useful part for a reader: the liver and the heart are not two separate problems to manage one at a time, but two readings of the same metabolic meter.
The food side of the same meter
The database is built on exactly this logic - the plate is the lever that moves the whole metabolic meter at once, not just the liver. The Recommended column lowers saturated share, added sugar, and processed load, which is the same set of changes that improves diastolic function. Fatty fish like salmon sit in Recommended at roughly 1.3 grams of saturated fat per 100 grams with omega-3s; rolled oats carry about 10 grams of fiber per 100 grams; olive oil is the default fat with low saturated share.
The specific per-food numbers are why the pattern works on both organs. A plate that keeps saturated share low and fiber high reduces the visceral fat and inflammation that stiffen the heart and the liver together. The study does not invent a new diet; it gives the existing pattern one more reason to be the default.
How our editorial team read this
We read cardiac-link studies with a specific discipline, because they tempt writers into the language of heart failure when the evidence is about an early, reversible measurement. Our data editor verified the study is cross-sectional - it shows association, not that MASLD causes the heart change - and kept the framing on “early diastolic dysfunction,” not heart failure. We did not turn a stiffness reading into a heart-failure warning.
What we did do is surface the part that is actionable: the same metabolic pattern that the database rates is the one the heart literature keeps pointing to, and a reader who manages the plate is managing both organs at once. The honest line is that the study adds the heart to the reason list, not a new rule to the plate.
The practical takeaway
For someone with MASLD, the diastolic study is a reminder to keep the heart in the same conversation as the liver - the blood pressure, the lipids, and the plate all move together. The database covers the food; the clinician covers the echocardiogram and the labs; the pattern is the part that stiffens neither organ.